Neuberger Berman Group LLC Exelixis, Inc. Transaction History

Neuberger Berman Group LLC

  • $118 Billion
  • Q1 2024

A detailed history of Neuberger Berman Group LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 18,918 shares of EXEL stock, worth $418,087. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,918
Holding current value
$418,087
% of portfolio
0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$20.17 - $23.93 $381,576 - $452,707
18,918 New
18,918 $448,000
Q4 2023

Feb 09, 2024
BUY
$19.25 - $24.13 $3,368 - $4,222
175 Added 0.92%
19,147 $459,000
Q3 2023

Nov 14, 2023
BUY
$19.04 - $22.74 $158,146 - $188,878
8,306 Added 77.87%
18,972 $414,000
Q2 2023

Aug 11, 2023
BUY
$18.17 - $20.48 $4,415 - $4,976
243 Added 2.33%
10,666 $203,000
Q1 2023

May 12, 2023
BUY
$16.3 - $19.41 $169,894 - $202,310
10,423 New
10,423 $202,000
Q3 2022

Nov 15, 2022
SELL
$15.68 - $22.27 $55,522 - $78,858
-3,541 Reduced 24.26%
11,057 $173,000
Q2 2022

Aug 15, 2022
SELL
$17.44 - $23.16 $48,116 - $63,898
-2,759 Reduced 15.9%
14,598 $304,000
Q1 2022

May 13, 2022
BUY
$17.03 - $22.67 $295,589 - $393,483
17,357 New
17,357 $391,000
Q3 2019

Nov 13, 2019
SELL
$17.68 - $22.65 $10.2 Million - $13.1 Million
-578,175 Closed
0 $0
Q2 2019

Aug 13, 2019
BUY
$18.93 - $24.75 $473 - $618
25 Added 0.0%
578,175 $12.4 Million
Q1 2019

May 13, 2019
SELL
$19.6 - $24.76 $3.78 Million - $4.78 Million
-192,938 Reduced 25.02%
578,150 $13.8 Million
Q4 2018

Feb 12, 2019
SELL
$13.65 - $21.8 $2.99 Million - $4.77 Million
-218,997 Reduced 22.12%
771,088 $15.2 Million
Q3 2018

Nov 13, 2018
BUY
$15.87 - $22.4 $304,037 - $429,139
19,158 Added 1.97%
990,085 $17.5 Million
Q2 2018

Aug 13, 2018
BUY
$18.56 - $22.45 $4.78 Million - $5.78 Million
257,568 Added 36.11%
970,927 $20.9 Million
Q1 2018

May 08, 2018
BUY
$22.15 - $31.89 $14.6 Million - $21 Million
659,201 Added 1217.18%
713,359 $15.8 Million
Q4 2017

Feb 14, 2018
SELL
$24.23 - $30.93 $857,233 - $1.09 Million
-35,379 Reduced 39.51%
54,158 $1.68 Million
Q3 2017

Nov 15, 2017
BUY
$23.35 - $29.24 $2.09 Million - $2.62 Million
89,537
89,537 $2.17 Million

Others Institutions Holding EXEL

# of Institutions
460
Shares Held
246M
Call Options Held
1.7M
Put Options Held
1.02M
View Full List

About EXELIXIS, INC.

EXEL Quotes by TradingView
  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $7.11B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email